Global Antivirals Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antivirals Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antivirals by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antivirals by Country/Region, 2017, 2022 & 2028

2.2 Antivirals Segment by Type

2.2.1 Generic

2.2.2 Branded

2.3 Antivirals Sales by Type

2.3.1 Global Antivirals Sales Market Share by Type (2017-2022)

2.3.2 Global Antivirals Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antivirals Sale Price by Type (2017-2022)

2.4 Antivirals Segment by Application

2.4.1 HIV

2.4.2 Hepatitis

2.4.3 HSV

2.4.4 Influenza

2.5 Antivirals Sales by Application

2.5.1 Global Antivirals Sale Market Share by Application (2017-2022)

2.5.2 Global Antivirals Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antivirals Sale Price by Application (2017-2022)

3 Global Antivirals by Company

3.1 Global Antivirals Breakdown Data by Company

3.1.1 Global Antivirals Annual Sales by Company (2020-2022)

3.1.2 Global Antivirals Sales Market Share by Company (2020-2022)

3.2 Global Antivirals Annual Revenue by Company (2020-2022)

3.2.1 Global Antivirals Revenue by Company (2020-2022)

3.2.2 Global Antivirals Revenue Market Share by Company (2020-2022)

3.3 Global Antivirals Sale Price by Company

3.4 Key Manufacturers Antivirals Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antivirals Product Location Distribution

3.4.2 Players Antivirals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antivirals by Geographic Region

4.1 World Historic Antivirals Market Size by Geographic Region (2017-2022)

4.1.1 Global Antivirals Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antivirals Annual Revenue by Geographic Region

4.2 World Historic Antivirals Market Size by Country/Region (2017-2022)

4.2.1 Global Antivirals Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antivirals Annual Revenue by Country/Region

4.3 Americas Antivirals Sales Growth

4.4 APAC Antivirals Sales Growth

4.5 Europe Antivirals Sales Growth

4.6 Middle East & Africa Antivirals Sales Growth

5 Americas

5.1 Americas Antivirals Sales by Country

5.1.1 Americas Antivirals Sales by Country (2017-2022)

5.1.2 Americas Antivirals Revenue by Country (2017-2022)

5.2 Americas Antivirals Sales by Type

5.3 Americas Antivirals Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antivirals Sales by Region

6.1.1 APAC Antivirals Sales by Region (2017-2022)

6.1.2 APAC Antivirals Revenue by Region (2017-2022)

6.2 APAC Antivirals Sales by Type

6.3 APAC Antivirals Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antivirals by Country

7.1.1 Europe Antivirals Sales by Country (2017-2022)

7.1.2 Europe Antivirals Revenue by Country (2017-2022)

7.2 Europe Antivirals Sales by Type

7.3 Europe Antivirals Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antivirals by Country

8.1.1 Middle East & Africa Antivirals Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antivirals Revenue by Country (2017-2022)

8.2 Middle East & Africa Antivirals Sales by Type

8.3 Middle East & Africa Antivirals Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antivirals

10.3 Manufacturing Process Analysis of Antivirals

10.4 Industry Chain Structure of Antivirals

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antivirals Distributors

11.3 Antivirals Customer

12 World Forecast Review for Antivirals by Geographic Region

12.1 Global Antivirals Market Size Forecast by Region

12.1.1 Global Antivirals Forecast by Region (2023-2028)

12.1.2 Global Antivirals Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antivirals Forecast by Type

12.7 Global Antivirals Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Antivirals Product Offered

13.1.3 Merck Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Company Information

13.2.2 Johnson & Johnson Antivirals Product Offered

13.2.3 Johnson & Johnson Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson & Johnson Main Business Overview

13.2.5 Johnson & Johnson Latest Developments

13.3 Teva Pharmaceutical Industries

13.3.1 Teva Pharmaceutical Industries Company Information

13.3.2 Teva Pharmaceutical Industries Antivirals Product Offered

13.3.3 Teva Pharmaceutical Industries Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Pharmaceutical Industries Main Business Overview

13.3.5 Teva Pharmaceutical Industries Latest Developments

13.4 GSK

13.4.1 GSK Company Information

13.4.2 GSK Antivirals Product Offered

13.4.3 GSK Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GSK Main Business Overview

13.4.5 GSK Latest Developments

13.5 Mylan

13.5.1 Mylan Company Information

13.5.2 Mylan Antivirals Product Offered

13.5.3 Mylan Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Mylan Main Business Overview

13.5.5 Mylan Latest Developments

13.6 Gilead Sciences

13.6.1 Gilead Sciences Company Information

13.6.2 Gilead Sciences Antivirals Product Offered

13.6.3 Gilead Sciences Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Gilead Sciences Main Business Overview

13.6.5 Gilead Sciences Latest Developments

13.7 F. Hoffmann-La Roche

13.7.1 F. Hoffmann-La Roche Company Information

13.7.2 F. Hoffmann-La Roche Antivirals Product Offered

13.7.3 F. Hoffmann-La Roche Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 F. Hoffmann-La Roche Main Business Overview

13.7.5 F. Hoffmann-La Roche Latest Developments

13.8 Bristol-Myers-Squibb

13.8.1 Bristol-Myers-Squibb Company Information

13.8.2 Bristol-Myers-Squibb Antivirals Product Offered

13.8.3 Bristol-Myers-Squibb Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bristol-Myers-Squibb Main Business Overview

13.8.5 Bristol-Myers-Squibb Latest Developments

13.9 AbbVie

13.9.1 AbbVie Company Information

13.9.2 AbbVie Antivirals Product Offered

13.9.3 AbbVie Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 AbbVie Main Business Overview

13.9.5 AbbVie Latest Developments

13.10 Aurobindo Pharma

13.10.1 Aurobindo Pharma Company Information

13.10.2 Aurobindo Pharma Antivirals Product Offered

13.10.3 Aurobindo Pharma Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Aurobindo Pharma Main Business Overview

13.10.5 Aurobindo Pharma Latest Developments

13.11 Cipla

13.11.1 Cipla Company Information

13.11.2 Cipla Antivirals Product Offered

13.11.3 Cipla Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Cipla Main Business Overview

13.11.5 Cipla Latest Developments

13.12 Dr Reddy’s

13.12.1 Dr Reddy’s Company Information

13.12.2 Dr Reddy’s Antivirals Product Offered

13.12.3 Dr Reddy’s Antivirals Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Dr Reddy’s Main Business Overview

13.12.5 Dr Reddy’s Latest Developments

14 Research Findings and Conclusion

Table 1. Antivirals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antivirals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Generic

Table 4. Major Players of Branded

Table 5. Global Antivirals Sales by Type (2017-2022) & (K MT)

Table 6. Global Antivirals Sales Market Share by Type (2017-2022)

Table 7. Global Antivirals Revenue by Type (2017-2022) & ($ million)

Table 8. Global Antivirals Revenue Market Share by Type (2017-2022)

Table 9. Global Antivirals Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Antivirals Sales by Application (2017-2022) & (K MT)

Table 11. Global Antivirals Sales Market Share by Application (2017-2022)

Table 12. Global Antivirals Revenue by Application (2017-2022)

Table 13. Global Antivirals Revenue Market Share by Application (2017-2022)

Table 14. Global Antivirals Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Antivirals Sales by Company (2020-2022) & (K MT)

Table 16. Global Antivirals Sales Market Share by Company (2020-2022)

Table 17. Global Antivirals Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Antivirals Revenue Market Share by Company (2020-2022)

Table 19. Global Antivirals Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Antivirals Producing Area Distribution and Sales Area

Table 21. Players Antivirals Products Offered

Table 22. Antivirals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Antivirals Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Antivirals Sales Market Share Geographic Region (2017-2022)

Table 27. Global Antivirals Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Antivirals Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Antivirals Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Antivirals Sales Market Share by Country/Region (2017-2022)

Table 31. Global Antivirals Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Antivirals Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Antivirals Sales by Country (2017-2022) & (K MT)

Table 34. Americas Antivirals Sales Market Share by Country (2017-2022)

Table 35. Americas Antivirals Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Antivirals Revenue Market Share by Country (2017-2022)

Table 37. Americas Antivirals Sales by Type (2017-2022) & (K MT)

Table 38. Americas Antivirals Sales Market Share by Type (2017-2022)

Table 39. Americas Antivirals Sales by Application (2017-2022) & (K MT)

Table 40. Americas Antivirals Sales Market Share by Application (2017-2022)

Table 41. APAC Antivirals Sales by Region (2017-2022) & (K MT)

Table 42. APAC Antivirals Sales Market Share by Region (2017-2022)

Table 43. APAC Antivirals Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Antivirals Revenue Market Share by Region (2017-2022)

Table 45. APAC Antivirals Sales by Type (2017-2022) & (K MT)

Table 46. APAC Antivirals Sales Market Share by Type (2017-2022)

Table 47. APAC Antivirals Sales by Application (2017-2022) & (K MT)

Table 48. APAC Antivirals Sales Market Share by Application (2017-2022)

Table 49. Europe Antivirals Sales by Country (2017-2022) & (K MT)

Table 50. Europe Antivirals Sales Market Share by Country (2017-2022)

Table 51. Europe Antivirals Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Antivirals Revenue Market Share by Country (2017-2022)

Table 53. Europe Antivirals Sales by Type (2017-2022) & (K MT)

Table 54. Europe Antivirals Sales Market Share by Type (2017-2022)

Table 55. Europe Antivirals Sales by Application (2017-2022) & (K MT)

Table 56. Europe Antivirals Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Antivirals Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Antivirals Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Antivirals Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Antivirals Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Antivirals Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Antivirals Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Antivirals Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Antivirals Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Antivirals

Table 66. Key Market Challenges & Risks of Antivirals

Table 67. Key Industry Trends of Antivirals

Table 68. Antivirals Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Antivirals Distributors List

Table 71. Antivirals Customer List

Table 72. Global Antivirals Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Antivirals Sales Market Forecast by Region

Table 74. Global Antivirals Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Antivirals Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Antivirals Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Antivirals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Antivirals Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Antivirals Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Antivirals Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Antivirals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Antivirals Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Antivirals Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Antivirals Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Antivirals Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Antivirals Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Antivirals Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Antivirals Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Antivirals Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Antivirals Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Antivirals Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Antivirals Product Offered

Table 94. Merck Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Johnson & Johnson Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 98. Johnson & Johnson Antivirals Product Offered

Table 99. Johnson & Johnson Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Johnson & Johnson Main Business

Table 101. Johnson & Johnson Latest Developments

Table 102. Teva Pharmaceutical Industries Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 103. Teva Pharmaceutical Industries Antivirals Product Offered

Table 104. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Teva Pharmaceutical Industries Main Business

Table 106. Teva Pharmaceutical Industries Latest Developments

Table 107. GSK Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 108. GSK Antivirals Product Offered

Table 109. GSK Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. GSK Main Business

Table 111. GSK Latest Developments

Table 112. Mylan Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 113. Mylan Antivirals Product Offered

Table 114. Mylan Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Mylan Main Business

Table 116. Mylan Latest Developments

Table 117. Gilead Sciences Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 118. Gilead Sciences Antivirals Product Offered

Table 119. Gilead Sciences Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Gilead Sciences Main Business

Table 121. Gilead Sciences Latest Developments

Table 122. F. Hoffmann-La Roche Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 123. F. Hoffmann-La Roche Antivirals Product Offered

Table 124. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. F. Hoffmann-La Roche Main Business

Table 126. F. Hoffmann-La Roche Latest Developments

Table 127. Bristol-Myers-Squibb Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 128. Bristol-Myers-Squibb Antivirals Product Offered

Table 129. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Bristol-Myers-Squibb Main Business

Table 131. Bristol-Myers-Squibb Latest Developments

Table 132. AbbVie Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 133. AbbVie Antivirals Product Offered

Table 134. AbbVie Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. AbbVie Main Business

Table 136. AbbVie Latest Developments

Table 137. Aurobindo Pharma Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 138. Aurobindo Pharma Antivirals Product Offered

Table 139. Aurobindo Pharma Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Aurobindo Pharma Main Business

Table 141. Aurobindo Pharma Latest Developments

Table 142. Cipla Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 143. Cipla Antivirals Product Offered

Table 144. Cipla Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Cipla Main Business

Table 146. Cipla Latest Developments

Table 147. Dr Reddy’s Basic Information, Antivirals Manufacturing Base, Sales Area and Its Competitors

Table 148. Dr Reddy’s Antivirals Product Offered

Table 149. Dr Reddy’s Antivirals Sales (K MT), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Dr Reddy’s Main Business

Table 151. Dr Reddy’s Latest Developments

List of Figures

Figure 1. Picture of Antivirals

Figure 2. Antivirals Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antivirals Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Antivirals Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antivirals Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Generic

Figure 10. Product Picture of Branded

Figure 11. Global Antivirals Sales Market Share by Type in 2021

Figure 12. Global Antivirals Revenue Market Share by Type (2017-2022)

Figure 13. Antivirals Consumed in HIV

Figure 14. Global Antivirals Market: HIV (2017-2022) & (K MT)

Figure 15. Antivirals Consumed in Hepatitis

Figure 16. Global Antivirals Market: Hepatitis (2017-2022) & (K MT)

Figure 17. Antivirals Consumed in HSV

Figure 18. Global Antivirals Market: HSV (2017-2022) & (K MT)

Figure 19. Antivirals Consumed in Influenza

Figure 20. Global Antivirals Market: Influenza (2017-2022) & (K MT)

Figure 21. Global Antivirals Sales Market Share by Application (2017-2022)

Figure 22. Global Antivirals Revenue Market Share by Application in 2021

Figure 23. Antivirals Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Antivirals Revenue Market Share by Company in 2021

Figure 25. Global Antivirals Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Antivirals Revenue Market Share by Geographic Region in 2021

Figure 27. Global Antivirals Sales Market Share by Region (2017-2022)

Figure 28. Global Antivirals Revenue Market Share by Country/Region in 2021

Figure 29. Americas Antivirals Sales 2017-2022 (K MT)

Figure 30. Americas Antivirals Revenue 2017-2022 ($ Millions)

Figure 31. APAC Antivirals Sales 2017-2022 (K MT)

Figure 32. APAC Antivirals Revenue 2017-2022 ($ Millions)

Figure 33. Europe Antivirals Sales 2017-2022 (K MT)

Figure 34. Europe Antivirals Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Antivirals Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Antivirals Revenue 2017-2022 ($ Millions)

Figure 37. Americas Antivirals Sales Market Share by Country in 2021

Figure 38. Americas Antivirals Revenue Market Share by Country in 2021

Figure 39. United States Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Antivirals Sales Market Share by Region in 2021

Figure 44. APAC Antivirals Revenue Market Share by Regions in 2021

Figure 45. China Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Antivirals Sales Market Share by Country in 2021

Figure 52. Europe Antivirals Revenue Market Share by Country in 2021

Figure 53. Germany Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Antivirals Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Antivirals Revenue Market Share by Country in 2021

Figure 60. Egypt Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Antivirals Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Antivirals in 2021

Figure 66. Manufacturing Process Analysis of Antivirals

Figure 67. Industry Chain Structure of Antivirals

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles